FDA Accepts Sanofi’s Diabetes Drug as NDA

23.02.2016 - The US Food and Drug Administration (FDA) has accepted Sanofi’s New Drug Application (NDA) for the French drugmaker’s investigational fixed-ratio combination of basal insulin...